Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
The Index Valve Matters: Optimal Index TAVI for Patients Lifetime Management
Author(s): Michael Joner Added: 2 months ago
In this interview, Prof Michael Joner (German Heart Centre, Munich, DE) discusses the specific needs and treatment considerations when managing low and intermediate risk TAVI patients. He also highlights the increasing need to consider future interventions when selecting the index valve.Prof Joner details the Navitor TAVI system resheathable design with intra-annular function, large-cell frame… View more

Intervention
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors
Author(s): Christina Magnussen Added: 11 months ago
ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global… View more

Cardiovascular Renal Metabolic
Acute Coronary Syndrome Post-TAVR with Dr Samineh Sehatbakhsh
Author(s): Samineh Sehatbakhsh Added: 6 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients… View more

Intervention
Combined Antithrombotic Regimens and the OPTIMA-AF trial
Author(s): Alberto Alperi , Paula Antuña , Juan Rondan , et al Added: 1 week ago

Anticoagulation

Intervention
Sex Difference in Relative Survival Following PCI
Author(s): Jin-Ho Choi , Jung-Min Choi , Ki-Hong Choi , et al Added: 1 year ago

Demographic

Intervention
Zalunfiban before PC
Author(s): Arina ten Cate-Hoek , Bianca Rocca Added: 1 week ago

Anticoagulation

MI/ACS
TCT 23: 5 Trials That Will Change My Practice
Author(s): Bernardo Cortese Added: 2 years ago
TCT 23 - We are joined by Dr Bernardo Cortese (Ospedale Fate bene Fratelli, IT) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.Trials covered in detail include:PARTNER 3Evolut Low RiskLIFE-BTKAGENT-IDETRANSFORM IRecorded remotely from Milano, 2023.Editor: Jordan RanceVideo Specialist: Dan Brent View more

Intervention

Vascular Disease and Surgery
AF Symposium 26: STYLE AF Update
Author(s): Roland R Tilz Added: 3 weeks ago
AF Symposium 2026 - Prof Roland Tilz (University Heart Center Lübeck, DE) presents updated findings from the STYLE AF study evaluating vascular closure strategies in patients undergoing atrial fibrillation ablation, with implications for procedural efficiency and same-day discharge protocols.Results demonstrated clear superiority of the vascular closure device across multiple clinically relevant… View more

Electrophysiology & Arrhythmia